You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仟源醫藥(300254.SZ):擬出資1000萬元於上海設立全資子公司 加快精麻等類別的新產品研發
格隆匯 11-25 17:33

格隆匯11月25日丨仟源醫藥(300254.SZ)公佈,2024年11月25日,公司第五屆董事會第二十三次會議審議通過了《關於設立全資子公司的議案》。公司擬以自有資金出資在上海設立全資子公司"仟源醫藥(上海)研究開發有限公司"(公司名稱最終以市場監督管理部門核准登記結果為準),該公司註冊資本為人民幣1,000萬元。子公司經營範圍包括一般項目:醫學研究和試驗發展;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣。

本次設立全資子公司是基於公司已取得多項精麻藥品實驗研究立項批件,本次設立全資研發子公司是為了更好的引進高端研發人才,加快精麻等類別的新產品研發,以增強公司的核心競爭力和持續發展能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account